Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heat Biologics Inc (NASDAQ:HTBX)

0.4976
Delayed Data
As of Aug 18
 -0.0024 / -0.48%
Today’s Change
0.46
Today|||52-Week Range
3.35
-41.80%
Year-to-Date
No recent news for Heat Biologics Inc.

Today’s Trading

Previous close0.50
Today’s open0.51
Day’s range0.48 - 0.51
Volume89,849
Average volume (3 months)287,337
Market cap$17.8M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+71.94%
Earnings growth (this year)+43.66%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales44.01
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
SLNOSoleno Therapeutics ...-0.05-12.64%
EYEGEyeGate Pharmaceutic...+0.09+9.68%
TRPXTherapix Biosciences...+0.04+0.71%
KTOVKitov Pharmaceutical...+0.02+1.16%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateAugust 21, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$341.6K
Annual profit (last year)-$12.6M
Net profit margin-3,680.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff A. Wolf
Chief Operating &
Scientific Officer
Jeff T. Hutchins
Corporate headquarters
Durham, North Carolina

Forecasts